#PancreaticCancer #CancerTreatment #MedicalInnovation
www.cbsnews.com
New treatment for inoperable pancreatic cancer form offers hope. Here's what Optune Pax does.
Carolyn Gusoff has covered some of the most high profile news stories in the New York City area and is best known as a trusted, tenacious, consistent and caring voice of Long Island's concerns.
N
#PancreaticCancer #EarlyDetection #CancerResearch
www.nih.gov
Researchers identify new blood markers that may detect early pancreatic cancer
NIH-funded, four-marker panel could one day help catch one of deadliest cancers at more treatable stages.
National Institutes of Health (NIH)-supported investigators have developed a blood test to find pancreatic ductal adenocarcinoma, one of the deadliest forms of cancer.
#PancreaticCancer #MedicalBreakthrough #CancerResearch
www.newsweek.com
Did scientists find pancreatic cancer cure? What to know about breakthrough
A major medical breakthrough might have been achieved while researching an eventual cure for pancreatic cancer, as a new study from scientists in Spain discovered that triple therapy could entirely eliminate it in mice.
#PancreaticCancer #CancerResearch #Immunotherapy
www.yahoo.com
Scientists may have found key to treating hidden cancer growths
Add Yahoo as a preferred source to see more of our stories on Google.
Scientists may have discovered the way in which pancreatic cancer - dubbed the "silent killer" - hides from the immune system, and how disrupting this process could help tumours to shrink.
#PancreaticCancer #HealthAwareness #SelfAdvocacy
www.newsweek.com
Mom thinks supplements are causing abdominal pain -- then gets shock diagnosis
A mom who lived with severe abdominal pain for months thought it was related to digestion, and she tried everything to improve her gut -- but nothing could prepare her for what a CT scan would later reveal.
#PancreaticCancer #CancerResearch #ClinicalTrials
markets.businessinsider.com
HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Na茂ve Pancreatic Ductal Adenocarcinoma
HONG KONG and SHANGHAI and FLORHAM PARK, N. J. , Jan. 05, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated the Phase III part of the Phase II/III trial to evaluate the efficacy of the combination of surufatinib, camrelizumab, nab-paclitaxel and gemcitabine as a first-line treatment for patients with metastatic pancreatic ductal adenocarcinoma ("PDAC") in China.
C
#CancerResearch #PancreaticCancer #ClinicalTrials
www.courant.com
Pancreatic cancer is among the deadliest cancers. A new drug being tested at Penn is giving patients and doctors hope
PHILADELPHIA -- Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to stage 4 less than a year after her initial diagnosis.
C
#CancerResearch #PancreaticCancer #ClinicalTrials
www.courant.com
Pancreatic cancer is among the deadliest cancers. A new drug being tested at Penn is giving patients and doctors hope
PHILADELPHIA -- Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to stage 4 less than a year after her initial diagnosis.
